eLIFE - the new open access journal for outstanding research in life sciences

eLife is a unique collaboration between the funders and practitioners of research to communicate ground-breaking discoveries in the life and biomedical sciences in the most effective way. The eLife journal is a platform for maximising the reach and influence of new discoveries and showcasing new approaches to the presentation, use, and assessment of research.
As an open-access journal, eLife delivers access to content for free, online, immediately on publication, and will encourage maximum possible reach and utility of the content by publishing under the terms of the Creative Commons Attribution License, which is emerging as the gold standard for open-access publishing. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust.
Learn more at elifesciences.org.

Journal trials accepting all articles it sends for peer review (eLife)
Freitag, 29. Juni 2018
The Open Access journal eLife (in which the MPG is also involved) wants to publish all contributions it accepts for peer review in a test run. The article should be published including all peer review documents. The final decision on publication should lie with the author - if errors are discovered in the review, the author can withdraw the work. So far eLife accepts about 30% of the submitted work for peer review, about half of it will then be published. The new procedure should help to ensure that the place of publication is no longer seen as a guarantee for a certain quality, but rather that discussions about a work are made more visible. The first test run for the new procedure is to comprise 300 papers. Link: Times Higher Education

Artikel über das neue Verfahren von Schekman und dem Editor Mark Patterson bei eLife: eLIFE Sciences